Expertise in
7
conditions

Gaku Yamanaka

Shinjuku, JP 
Expertise in
7
conditions
Shinjuku, JP 

Overview

Gaku Yamanaka practices practicing medicine in Shinjuku, Japan.

Yamanaka is highly rated in 7 conditions, according to our data. Their clinical expertise encompasses West Syndrome, Migraine, Genetic Epilepsy with Febrile Seizures Plus (GEFS+), Respiratory Syncytial Virus (RSV) Infection, and Tissue Biopsy.

They are actively involved in clinical research, co-authoring 99 peer reviewed articles and participating in 4 clinical trials.

Locations

Shinjuku, 1600023, Japan
Other Locations
Tokyo, Japan
Nishishinjuku, 1600023, Japan
Shinjiku, Japan
Yokohama, Japan
The Japanese Society Of Child Neurology, Japan
Arakawa, 1168567, Japan

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

4 Clinical Trials

Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Pediatric Options for Migraine Relief: A Randomized, Double-Blind, Placebo-Controlled Study of Lasmiditan for Acute Treatment of Migraine: PIONEER-PEDS1
Enrollment Status: Terminated
Publish Date: September 02, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
A Phase 3, 12-Month, Open-Label Study of Lasmiditan in Pediatric Patients With Migraine - PIONEER-PEDS2
Enrollment Status: Terminated
Publish Date: June 25, 2026
Intervention Type: Drug
Study Drug: Lasmiditan
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Adolescent Patients 12 to 17 Years of Age With Chronic Migraine - the REBUILD-2 Study
Enrollment Status: Active_not_recruiting
Publish Date: February 27, 2026
Intervention Type: Drug
Study Drug: Galcanezumab
Study Phase: Phase 3
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
A Randomized, Double-Blind, Placebo-Controlled Study of Galcanezumab in Patients 6 to 17 Years of Age With Episodic Migraine - the REBUILD-1 Study
Enrollment Status: Active_not_recruiting
Publish Date: January 26, 2026
Intervention Type: Drug
Study Phase: Phase 3
View 3 Less Clinical Trials

99 Total Publications

A Case of Autosomal Dominant Alport Syndrome Diagnosed Just Before Discontinuation of Follow-Up.
A Case of Autosomal Dominant Alport Syndrome Diagnosed Just Before Discontinuation of Follow-Up.
Journal: Pediatric reports
Published: April 16, 2026

Frequently Asked Questions about Gaku Yamanaka

Is Gaku Yamanaka a top-rated expert for West Syndrome?

MediFind is an objective health platform that identifies experts based on real-world data. Gaku Yamanaka is classified as an Advanced expert for West Syndrome, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.

Does Gaku Yamanaka participate in research or clinical trials?

Yes. Gaku Yamanaka has published 99 articles and abstracts on conditions like West Syndrome. You can view a list of Gaku Yamanaka's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Yamanaka's expertise for a condition
ConditionClose
      View All 7 Advanced Conditions
      View All 66 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile